Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT

被引：5

作者：

Waszczuk-Gajda, Anna ^{[1
]}

Gras, Luuk ^{[2
]}

de Wreede, Liesbeth C. ^{[3
]}

Sirait, Tiarlan ^{[4
]}

Illes, Arpad ^{[5
]}

Ozkurt, Zubeyde Nur ^{[6
]}

Snowden, John A. ^{[7
]}

Arat, Mutlu ^{[8
]}

Bulabois, Claude Eric ^{[9
]}

Niederland, Judith ^{[10
]}

Sever, Matjaz ^{[11
]}

Paneesha, Shankara ^{[12
]}

Potter, Victoria ^{[13
]}

Gadisseur, Alain ^{[14
]}

Chalopin, Thomas ^{[15
]}

Van Gorkom, Gwendolyn ^{[16
]}

Lopez, Joaquin Martinez ^{[17
]}

Kerre, Tessa ^{[18
]}

Drozd-Sokolowska, Joanna ^{[1
]}

Raj, Kavita ^{[19
]}

Hayden, Patrick J. ^{[20
]}

Beksac, Meral ^{[21
]}

Yakoub-Agha, Ibrahim ^{[22
]}

McLornan, Donal P. ^{[19
]}

Schoenland, Stefan ^{[23
]}

机构：

[1] Med Univ Warsaw, Univ Clin Ctr, Warsaw, Poland

[2] EBMT Stat Unit, Leiden, Netherlands

[3] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands

[4] EBMT Leiden Study Unit, Leiden, Netherlands

[5] Univ Debrecen, Fac Med, Debrecen, Hungary

[6] Gazi Univ, Fac Med, Dept Hematol, Ankara, Turkiye

[7] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, England

[8] Demiroglu Bilim Univ, Istanbul Florence Nightingale Hosp, Istanbul, Turkiye

[9] Univ Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France

[10] HELIOS Klinikum Berlin Buch, Judith Niederland, Berlin, Germany

[11] Univ Ljubljana, Univ Med Ctr, Slovenia Fac Med, Ljubljana, Slovenia

[12] Univ Hosp Birmingham NHS Fdn Trust, Dept Haematol, Birmingham, England

[13] Kings Coll Hosp London, London, England

[14] Antwerp Univ Hosp UZA, Alain Gadisseur, Antwerp, Belgium

[15] Hop Bretonneau, Tours, France

[16] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Internal Med, Div Hematol,Med Ctr, NL-6229 HX Maastricht, Netherlands

[17] Hosp Univ 12 Octubre, Madrid, Spain

[18] Ghent Univ Hosp, Ghent, Belgium

[19] Univ Coll London Hosp NHS Trust, London, England

[20] Trinity Coll Dublin, Sch Med, Dept Haematol, Dublin, Ireland

[21] Ankara Univ, Fac Med, Ankara, Turkiye

[22] Univ Lille, CHU Lille, INSERM, Infin,U1286, F-59000 Lille, France

[23] Heidelberg Univ, Med Klin Poliklin 5, Heidelberg, Germany

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 04期

关键词：

MULTIPLE-MYELOMA; RENAL-FAILURE; BORTEZOMIB; INSUFFICIENCY; LENALIDOMIDE; MULTICENTER; SCT;

D O I：

10.1038/s41409-023-01915-7

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

The role of high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) in the treatment of myeloma (MM) patients with severe and/or dialysis-dependent renal impairment remains uncertain. We report on the outcomes of 110 patients (median age 57 years) who had become dialysis-dependent pre-ASCT and who underwent a first ASCT between 1997 and 2017. Sixty-three (57%) patients had light chain MM. All patients required dialysis (94% hemodialysis and 6% peritoneal). Forty-four of 71 (62%) patients received bortezomib-based induction regimens and 42 (39%) patients had achieved at least a very good partial response (VGPR) pre-ASCT. Melphalan dosing was as follows: <= 140 mg/m(2) (82%), and >140 mg/m(2) (18%). The median PFS after ASCT was 35 months (95% CI: 21.5-42.2) and the median OS 102 months (95% CI: 70.4-129.1). At 1, 2, and 5 years after ASCT, 8% (95% CI 3-14%), 13% (6-20%), and 20% (12-29%) of patients, respectively, had achieved dialysis independence. In multivariate analyses of OS and PFS including age at ASCT, response at ASCT, and year of ASCT, younger age at ASCT and better response at ASCT (CR/VGPR/PR vs. MR/SD/progression) were significantly associated with better OS and PFS.

引用

页码：424 / 429

页数：6

共 50 条

[41] First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study [J].

Martino, Massimo ;

Gori, Mercedes ;

Porto, Gaetana ;

Policastro, Giorgia ;

Pitea, Martina ;

Sgarlata, Annalisa ;

Delfino, Ilaria Maria ;

Cogliandro, Francesca ;

Scopelliti, Anna ;

Utano, Giovanna ;

Pellicano, Maria ;

Idato, Aurora ;

Vincelli, Iolanda Donatella ;

Marafioti, Violetta ;

Mico, Maria Caterina ;

Lazzaro, Giuseppe ;

Loteta, Barbara ;

Alati, Caterina ;

Leanza, Giovanni ;

D'Arrigo, Graziella ;

Tripepi, Giovanni Luigi ;

Pitino, Annalisa .

CANCERS, 2024, 16 (19)

[42] Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT) [J].

Saraceni, Francesco ;

Labopin, Myriam ;

Forcade, Edouard ;

Kroeger, Nicolaus ;

Socie, Gerard ;

Niittyvuopio, Riitta ;

Cornelissen, Jan J. ;

Labussiere-Wallet, Helene ;

Blaise, Didier ;

Choi, Goda ;

Byrne, Jenny L. ;

Guillerm, Gaelle ;

Marchand, Tony ;

Esteve, Jordi ;

Bazarbachi, Ali ;

Savani, Bipin ;

Olivieri, Attilio ;

Nagler, Arnon ;

Mohty, Mohamad .

CANCER MEDICINE, 2021, 10 (01) :23-33

[43] Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial [J].

Tanaka, Keisuke ;

Toyota, Shigeo ;

Akiyama, Megumi ;

Wakimoto, Naoki ;

Nakamura, Yuichi ;

Najima, Yuho ;

Doki, Noriko ;

Kakihana, Kazuhiko ;

Igarashi, Aiko ;

Kobayashi, Takeshi ;

Ohashi, Kazuteru ;

Kudo, Daisuke ;

Shinagawa, Atsushi ;

Takano, Hina ;

Fujio, Takayuki ;

Okoshi, Yasushi ;

Hori, Mitsuo ;

Kumagai, Takashi ;

Saito, Tatsuya ;

Mukae, Junichi ;

Yamamoto, Koh ;

Tsutsumi, Ikuyo ;

Komeno, Takuya ;

Yoshida, Chikashi ;

Yamamoto, Masahide ;

Kojima, Hiroshi .

ACTA HAEMATOLOGICA, 2019, 141 (02) :111-118

[44] Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim [J].

Marchesi, Francesco ;

Terrenato, Irene ;

Papa, Elena ;

Tomassi, Martina ;

Falcucci, Paolo ;

Gumenyuk, Svitlana ;

Palombi, Francesca ;

Pisani, Francesco ;

Renzi, Daniela ;

Romano, Atelda ;

Spadea, Antonio ;

Regazzo, Giulia ;

Rizzo, Maria Giulia ;

De Rienzo, Mafalda ;

Ripellino, Claudio ;

Sgromo, Simona ;

Viggiani, Caterina ;

Ponte, Eleonora ;

Kayal, Ramy ;

Cordone, Iole ;

Foddai, Maria Laura ;

Mengarelli, Andrea .

ANNALS OF HEMATOLOGY, 2024, 103 (3) :947-956

[45] Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study [J].

Pellegrino Musto ;

Vittorio Simeon ;

Alberto Grossi ;

Francesca Gay ;

Sara Bringhen ;

Alessandra Larocca ;

Roberto Guariglia ;

Giuseppe Pietrantuono ;

Oreste Villani ;

Giovanni D’Arena ;

Carmela Cuomo ;

Clelia Musto ;

Fortunato Morabito ;

Maria Teresa Petrucci ;

Massimo Offidani ;

Elena Zamagni ;

Paola Tacchetti ;

Concetta Conticello ;

Giuseppe Milone ;

Antonio Palumbo ;

Michele Cavo ;

Mario Boccadoro .

Stem Cell Research & Therapy, 6

[46] Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study [J].

Partanen, Anu ;

Turunen, Antti ;

Silvennoinen, Raija ;

Valtola, Jaakko ;

Pyorala, Marja ;

Siitonen, Timo ;

Sikio, Anu ;

Putkonen, Mervi ;

Sankelo, Marja ;

Penttila, Karri ;

Kuittinen, Taru ;

Mantymaa, Pentti ;

Pelkonen, Jukka ;

Jantunen, Esa ;

Varmavuo, Ville .

JOURNAL OF CLINICAL APHERESIS, 2023, 38 (01) :33-44

[47] A Phase I/II Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study [J].

Park, Sung-Soo ;

Kim, Kihyun ;

Kim, Seok-Jin ;

Lee, Jae Hoon ;

Yoon, Sung Soo ;

Mun, Yeung Chul ;

Lee, Je-Jung ;

Eom, Hyeon-Seok ;

Kim, Jin Seok ;

Min, Chang-Ki .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) :1312-1319

[48] A phase I/II, open-label, prospective, multicenter study to evaluate the efficacy and safety of lower doses of bortezomib plus busulfan and melphalan as a conditioning regimen in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation: The KMM103 study [J].

Min, Chang Ki ;

Park, Sung-Soo .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) :E216-E216

[49] Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry [J].

Redder, Louise ;

Klausen, Tobias W. ;

Vangsted, Annette Juul ;

Gregersen, Henrik ;

Andersen, Niels F. ;

Pedersen, Robert S. ;

Szabo, Agoston G. ;

Frederiksen, Mikael ;

Frolund, Ulf C. ;

Helleberg, Carsten ;

Nielsen, Lene Kongsgaard ;

Pedersen, Per T. ;

Salomo, Morten ;

Gimsing, Peter ;

Frederiksen, Henrik ;

Abildgaard, Niels .

BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) :119-124

[50] Safety, effectiveness and pharmacokinetics of high-dose propylene glycol-free melphalan (EVOMELA) with a prolonged infusion as myeloablative conditioning in Chinese multiple myeloma patients undergoing autologous stem cell transplantation: A prospective phase iv study [J].

Wang, Fengrong ;

Cai, Zhen ;

Zou, Dehui ;

Chen, Wenming ;

Song, Yongping ;

Fu, Chengcheng ;

Hu, Jiong ;

Yang, Ting ;

Chen, Xinchuan ;

Yan, Jinsong ;

Liu, Kaiyan .

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025,

← 1 2 3 4 5 →